Ifg Share News (IFP)

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 15 March Old MutualFull Year ResultsPhoenix GroupFull Year GroupFull 16

CANADA STOCKS-TSX closes higher as trade war fears recede

(Adds details, updates to close) TORONTO, March 5 (Reuters) - Canada's main stock index closed higher in its first positive session in five, on

UK Earnings, Trading Statements Calendar - Next 7 Days

Financials, insurers pace drops

(ShareCast News) - The latest Brexit poll results sent traders scurrying for cover as they revealed another small lurch towards the UK leaving the European Union on 23 June. Although most analysts appeared wary of trusting the results of polls, especially those of the on-line variety, on Monday book

Tuesday broker round-up UPDATE

APR Energy: Goldman Sachs reduces target price from 1165p to 1039p, while upgrading to buy. Aureus Mining: FinnCap places its target price (prev.: 175p) under review and keeps its buy recommendation . Al Noor Hospitals: Jefferies increases target price from 1065p to 1155p and maintains a buy recom

Wednesday broker round-up UPDATE

Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation. Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral. British Land: Jefferies downgrades to hold with a target price of 707p. Brooks Macdonald Group: Canaccord

Broker tips: Serco, Berkeley Group, IFG

Serco has made positive steps to rebuilding its reputation with the UK government after winning a contract extension with the Minister of Justice (MoJ), according to Panmure Gordon. The service group expanded its contract to build and run an extension to HMP Thameside in south-east London, worth a

Broker snap: N+1 Singer lowers IFG to hold from buy

Friday´s announcement of an 'approach' for IFG Group came as little surprise to analysts at N+1 Singer, given that the company has been undervalued for an extended period of time and the sustained positive key performance indicators (KPIs) at James Hay, strong balance sheet and relative recent dispo

Wednesday broker round-up UPDATE

Abbey Protection: Numis lowers target price from 120p to 110p keeping a hold recommendation. Antofagasta: Investec takes target price from 707p to 725p, but still recommends selling. Ashtead Group: Numis ups target price from 640p to 670p and retains a hold recommendation. Panmure Gordon increases

Wednesday broker round-up UPDATE

Altitude Group: WH Ireland initiates with a target price of 50p and a buy recommendation. Betfair Group: Deutsche Bank increases target price from 725p to 884p, while staying with its hold recommendation. Nomura raises target price from 766p to 883p and reiterates a neutral rating. Exane BNP ups ta

Tracsis tech officer ditches shares

Raymond Kwan, the Chief Technical Officer of Tracsis ditched 750,000 shares on the same day the firm announced that it considers it likely that the company will exceed current market expectations for the year ended July 31st 2012. Tracsis is a developer, supplier and aggregator of resource optimis

Two Fenner directors snap up shares

John Sheldrick, a Non-Executive Director of FTSE 250 polymer technology firm Fenner, bought himself 10,000 shares just one day after the company unveiled a 53 per cent increase in pre-tax profit. Sheldrick purchased the shares for 440p each, for a total of £44,000. This represents 0.005% of Fenner

Small caps round-up: Scancell, Keller, Goldenport...

Scancell Holdings, a developer of therapeutic cancer vaccines, has announced that its protein ImmunoBody vaccine patent has been approved in the US. The patent, which has already been approved in Europe and Australia, will further strengthen Scancell's IP position around its proprietary ImmunoBody v

GlaxoSmithKline director sells off shares

Jean Stéphenne, president and general manager of Biologicals at GlaxoSmithKline, has sold off 20,000 shares just days after the firm off-loaded its Consumer Healthcare Consumer Healthcare over-the-counter brands. The director, who sold the shares at £14.408, has overseen Biologicals since 1991. E

CSC deputy goes on a shopping trip

John Whittaker, deputy chairman of Capital Shopping Centres Group, owner of the Trafford Centre, has done a spot of shopping himself. Whittaker, who is also a non-executive of the firm, purchased 50,000 shares at 310.60p per share for a total of £155,300. He joined the firm in January, as part o